TNS3 Antibody

What is TNS3 and why is it significant in cell biology research?

TNS3 (Tensin-3) is a 155 kDa (calculated) protein that plays crucial roles in actin remodeling, focal adhesion dynamics, and the dissociation of integrin-tensin-actin complexes. It represents a significant research target because it functions in critical cellular processes including cell migration and adhesion. TNS3 has been implicated in mammary cell migration and bone development, with particular research interest stemming from its involvement in cancer cell behavior . The protein contains distinctive SH2 and PTB domains that facilitate interactions with various signaling molecules, making it an important component in cellular signaling pathways related to migration and transformation .

What are the primary applications for TNS3 antibodies in research?

TNS3 antibodies have demonstrated utility across multiple research applications:

Researchers should note that optimal dilutions may vary by application and should be determined empirically for each experimental system .

What species reactivity can be expected with commercially available TNS3 antibodies?

The reactivity profile of TNS3 antibodies varies by product and manufacturer. Many commercially available TNS3 antibodies demonstrate reactivity with human, mouse, and rat samples . Some antibodies offer broader cross-reactivity to species including cow, dog, guinea pig, rabbit, hamster, and monkey, particularly those targeting highly conserved regions of the protein . When selecting an antibody for a particular species, researchers should carefully review the documented reactivity and consider conducting preliminary validation experiments if working with non-standard research organisms.

How should I optimize TNS3 antibody usage for Western blot applications?

For optimal Western blot detection of TNS3:

• Sample preparation: Use fresh tissue or cell lysates prepared with phosphatase inhibitors, particularly when studying phosphorylation states of TNS3

• Loading controls: Include appropriate loading controls when comparing TNS3 expression across samples

• Dilution optimization: Begin with manufacturer's recommended dilution (typically 1:500-1:1000) and titrate as needed

• Expected molecular weight: While calculated at 155 kDa, TNS3 typically appears around 129 kDa on Western blots

• Blocking conditions: Use 5% non-fat milk or BSA in TBST, with BSA preferred when detecting phosphorylated forms of TNS3

• Incubation time: Overnight primary antibody incubation at 4°C often yields optimal results with reduced background

Note that TNS3 antibodies recognize all isoforms of the protein, which may result in multiple bands depending on tissue type and experimental conditions .

What are the best practices for immunohistochemical detection of TNS3?

For successful IHC detection of TNS3, researchers should:

• Fixation: Use 10% neutral buffered formalin for tissue fixation

• Antigen retrieval: Implement heat-induced epitope retrieval using TE buffer pH 9.0 (alternatively, citrate buffer pH 6.0 can be used)

• Blocking: Block endogenous peroxidase activity and non-specific binding

• Antibody dilution: Begin with 1:50-1:500 dilution range and optimize

• Controls: Include positive control tissues (mouse kidney or embryo tissues have shown positive results)

• Detection system: Use a sensitive detection system appropriate for the primary antibody species

• Counterstaining: Apply hematoxylin counterstaining for nuclear visualization

The subcellular localization pattern should be evaluated, as TNS3 typically shows localization to focal adhesions and partial co-localization with FAK and p130Cas .

How can I validate TNS3 antibody specificity for my experiments?

Comprehensive validation of TNS3 antibody specificity should include:

• Positive controls: Test known TNS3-expressing tissues/cells (e.g., mouse kidney tissue for WB, mouse embryo tissue for IHC)

• Negative controls: Omit primary antibody to assess secondary antibody specificity

• Knockdown/knockout verification: Use siRNA-mediated TNS3 knockdown or CRISPR-edited cells lacking TNS3 expression to confirm signal specificity

• Peptide competition: Pre-incubate antibody with immunizing peptide to demonstrate binding specificity

• Multiple antibody comparison: Use antibodies targeting different TNS3 epitopes to confirm consistent detection patterns

• Cross-reactivity assessment: Test potential cross-reactivity with other tensin family members (TNS1, TNS2, TNS4)

These validation steps become particularly important when exploring TNS3 in novel experimental systems or when comparing results across different antibodies.

How can TNS3 antibodies be utilized in cancer research models?

TNS3 antibodies offer valuable tools for cancer research applications:

• Expression analysis: Evaluate TNS3 expression patterns across cancer cell lines and tumor tissues

• Functional studies: Combined with siRNA-mediated knockdown, examine TNS3's contribution to cancerous phenotypes

• Metastatic potential: Assess TNS3's role in cell migration as it relates to metastatic behavior

• Signaling pathway analysis: Investigate TNS3's interactions with oncogenic pathways, particularly Src signaling

• Phosphorylation dynamics: Study TNS3 phosphorylation states in response to growth factors and kinase inhibitors

Research has demonstrated that TNS3 contributes to cell migration, anchorage-independent growth, and wound healing in lung cancer, breast cancer, and melanoma cell lines . TNS3 reduction via siRNA strongly inhibited growth in soft agar and cell migration in these cancer models, suggesting its potential as a therapeutic target or biomarker .

What insights can TNS3 antibodies provide about cytoskeletal dynamics and focal adhesions?

TNS3 antibodies enable detailed investigation of cytoskeletal regulation:

• Focal adhesion composition: Immunofluorescence with TNS3 antibodies reveals co-localization with other focal adhesion proteins

• Actin remodeling: Study TNS3's role in regulating actin cytoskeleton dynamics during cell movement

• Integrin signaling: Examine how TNS3 influences integrin-mediated adhesion and downstream signaling

• Temporal dynamics: Track TNS3 recruitment and dissociation from adhesion complexes during migration

• Mechanical transduction: Investigate TNS3's potential role in translating mechanical cues to biochemical signals

Immunofluorescence studies have confirmed endogenous TNS3 localization to focal adhesions and its partial co-localization with FAK and p130Cas in cancer cell lines . This localization pattern provides insights into TNS3's functional role in adhesion dynamics and cell motility.

How does the phosphorylation status of TNS3 affect its function and detection?

TNS3 phosphorylation represents an important regulatory mechanism:

• Phosphorylation sites: TNS3 contains multiple tyrosine phosphorylation sites, including those within its SH2 domain

• Kinase interactions: Src and PDGFR can directly phosphorylate TNS3, with Src demonstrating more robust phosphorylation

• Detection methods: Phospho-specific antibodies or general phosphotyrosine antibodies combined with TNS3 immunoprecipitation can detect phosphorylated TNS3

• Functional consequences: Phosphorylation may regulate TNS3's interactions with binding partners and influence its cellular localization

• Signaling contexts: EGF treatment leads to TNS4 activation and TNS3 down-regulation, affecting integrin dynamics

In experimental settings, treating cells with kinase inhibitors like PP2 (Src inhibitor) reduces complex formation between TNS3 and p130Cas, demonstrating how phosphorylation regulates protein-protein interactions .

What are common challenges when using TNS3 antibodies and how can they be addressed?

Researchers may encounter several challenges when working with TNS3 antibodies:

• Background signal: Optimize blocking conditions (5% BSA may reduce background) and increase washing steps

• Inconsistent detection: Ensure proper sample handling with protease and phosphatase inhibitors

• Multiple bands: TNS3 exists in multiple isoforms; verify band patterns against positive controls

• Cross-reactivity: Select antibodies with validated specificity against other tensin family members

• Tissue-specific expression: Be aware that TNS3 expression varies across tissues, necessitating appropriate positive controls

• Antibody storage: Store according to manufacturer recommendations (-20°C with glycerol and sodium azide)

When troubleshooting, systematic optimization of each experimental parameter is recommended, beginning with validated protocols and positive control samples.

How can I design experiments to distinguish TNS3 from other tensin family members?

Discriminating between tensin family members requires careful experimental design:

• Antibody selection: Choose antibodies targeting unique regions not conserved across tensin family members

• Molecular weight differentiation: TNS3 (observed at ~129 kDa) differs from TNS1 (~220 kDa), TNS2 (~150 kDa), and TNS4 (~80 kDa)

• Domain-specific antibodies: Select antibodies targeting unique domains or regions specific to TNS3

• Knockdown controls: Include siRNA knockdowns for multiple tensin family members to confirm antibody specificity

• Functional assays: Compare phenotypic outcomes when manipulating different tensin family members

Research has shown distinct functional roles for tensin family members, with TNS3 having more pronounced effects on cancer cell migration and anchorage-independent growth compared to TNS1 in several cancer cell lines .

What considerations are important when studying TNS3 phosphorylation dynamics?

When investigating TNS3 phosphorylation:

• Sample preparation: Include phosphatase inhibitors in all buffers to preserve phosphorylation status

• Stimulation protocols: Consider time-course experiments following growth factor stimulation (e.g., EGF, PDGF)

• Inhibitor studies: Use specific kinase inhibitors (e.g., PP2 for Src inhibition) to dissect responsible kinases

• Detection methods: Combine immunoprecipitation with phosphotyrosine immunoblotting or use phospho-specific antibodies

• Functional correlation: Connect phosphorylation changes to functional outcomes like protein interactions or cellular processes

• Domain mapping: Different TNS3 fragments (1-440, 416-931, 1136-1445) may be phosphorylated at different sites

Studies have demonstrated that tensin-3 phosphorylation is dependent on Src activity, with recombinant active Src directly phosphorylating TNS3 in immune complexes - an effect that can be prevented by the Src inhibitor PP2 .

How does TNS3 function compare to other members of the tensin family in experimental models?

Comparative analysis of tensin family members reveals:

• Functional redundancy: Some overlap exists between tensin family members, but with distinct specialized roles

• Cancer context: TNS3 shows stronger effects on migration and anchorage-independent growth compared to TNS1 in several cancer cell lines

• Expression patterns: Tissue-specific expression differs between tensin family members

• Structural similarities: All tensins contain SH2 and PTB domains, but with varying N-terminal regions

• Regulatory mechanisms: While EGF activates TNS4, it down-regulates TNS3, suggesting opposite functions in certain contexts

In functional studies using siRNA-mediated knockdown, reduction of TNS3 in NSCLC and melanoma lines strongly inhibited growth in agar and cell migration, whereas reduction of TNS1 had limited effects .

What emerging technologies are enhancing TNS3 research beyond traditional antibody applications?

Advanced technologies expanding TNS3 research include:

• CRISPR-Cas9 gene editing: Creating precise TNS3 knockout or knock-in cell lines for functional studies

• Live-cell imaging: Using fluorescently tagged TNS3 to track dynamic localization during cellular processes

• Proximity labeling: BioID or APEX2 fusion proteins to identify novel TNS3 interactors in living cells

• Mass spectrometry: Identifying TNS3 phosphorylation sites and interaction partners with high precision

• Super-resolution microscopy: Revealing nanoscale organization of TNS3 at focal adhesions

• Single-cell analysis: Examining TNS3 expression heterogeneity across cell populations

These approaches complement traditional antibody-based methods, providing deeper insights into TNS3 biology and function.

What are the significant knowledge gaps in TNS3 biology that researchers are currently addressing?

Key research frontiers in TNS3 biology include:

• Structural biology: Detailed structural characterization of TNS3 domains and their interactions

• Tissue-specific functions: Understanding TNS3's role across different tissues beyond cancer models

• Interactome mapping: Comprehensive identification of TNS3 binding partners across cellular contexts

• Regulatory mechanisms: Elucidating transcriptional and post-translational regulation of TNS3

• In vivo significance: Translating in vitro findings to physiological and pathological contexts

• Therapeutic potential: Evaluating TNS3 as a target or biomarker in cancer and other diseases

• Cross-talk with other signaling pathways: Understanding how TNS3 integrates with broader cellular signaling networks

Research has established TNS3's involvement in cell migration and transformation, particularly in cancer contexts, but many aspects of its regulation and tissue-specific functions remain to be fully characterized .